Aerosol inhalation aid
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of an aerosol inhalation aid showing our new design;
FIG. 2 is a front elevational view thereof, the rear elevational view being identical thereto;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a right side elevational view thereof;
FIG. 6 is a top plan view thereof; and,
FIG. 7 is a front elevational view thereof in extended position, the rear elevational view being identical thereto.
The broken line showing in FIGS. 1, 2, 5, 6 and 7 is for illustrative purposes only and forms no part of the claimed design.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
D262320 | December 15, 1981 | Mono D24110 |
8802267 | April 1988 | DKX |
1544440 | February 1990 | SUX |
2110543 | June 1983 | GBX |
Patent History
Patent number: D339192
Type: Grant
Filed: May 3, 1991
Date of Patent: Sep 7, 1993
Assignee: Glaxo Group Limited (London)
Inventors: James H. Nicholson (Croxley Green), Michael McCurry (Barley Mow)
Primary Examiner: Stella Reid
Assistant Examiner: I. Simmons
Law Firm: Darby & Darby
Application Number: 7/695,246
Type: Grant
Filed: May 3, 1991
Date of Patent: Sep 7, 1993
Assignee: Glaxo Group Limited (London)
Inventors: James H. Nicholson (Croxley Green), Michael McCurry (Barley Mow)
Primary Examiner: Stella Reid
Assistant Examiner: I. Simmons
Law Firm: Darby & Darby
Application Number: 7/695,246
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)